AGREEMENTSchedule 13g Agreement • November 3rd, 2022 • Perceptive Advisors LLC • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 3rd, 2022 Company IndustryThe persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.